Pipeline – Temple Therapeutics

Improving Patient Outcomes.

A pipeline of synergistic, highly differentiated diagnostic and drug candidates leverage our novel cellular metabolism approach.

Targeted Therapeutics & Validated Diagnostics Driven by Female Biology Data

A single-dose therapy that inhibits fibrotic tissue growth at the surgical site.

Change to: A clinically validated non-invasive diagnostic platform and novel disease modifying non-hormonal targets.

A novel biomarker for early detection coupled with a novel target and molecule for ovarian cancer, promotes better outcomes.